# How to Compare Lab Results Over Time: Building Your Biomarker Trend
Meaningful progress tracking requires comparing apples to apples. A single lab result is a snapshot; trends over 6-12 months reveal what's actually working. But comparing results inconsistently leads to false conclusions.
The Consistency Principle: Same Lab, Same Conditions
Rule 1: Use the same laboratory
Different labs use different equipment, assays, and reference ranges. A testosterone result of 650 ng/dL at Lab A might correspond to 680 ng/dL at Lab B—the difference is the assay, not a real change in your hormones.
How to implement:
•Choose one lab (e.g., Quest Diagnostics, LabCorp, or a local hospital lab)
•Use that lab for every draw
•If you must switch labs (moving, insurance change), note it and run both labs once to establish the conversion
Rule 2: Same time of day
Hormones follow circadian rhythms. IGF-1 is 10-15% higher in early morning (7-9 AM) than mid-afternoon. Cortisol can vary 50%+ depending on time of day.
How to implement:
•Test at the same time each month: always 8 AM, always Tuesday mornings
•If you occasionally test at a different time, note it explicitly
•Allow 4-6 weeks of data before drawing conclusions (one anomalous time-of-day draw shouldn't change your decision)
Rule 3: Same fasting status
A fed glucose is 50-100 mg/dL higher than fasted. Triglycerides skyrocket after meals. Compare fasted to fasted, fed to fed, never mix.
How to implement:
•Always fast 8-12 hours before draws
•Keep the fasting window consistent (e.g., always 10-12 hours, not varying between 8-14)
•Log fasting status with each draw
Rule 4: Same day of cycle (for hormonal markers if applicable)
For women tracking hormones, test on the same day of your menstrual cycle each month. Hormone levels swing dramatically through the cycle; comparing day 7 to day 21 looks like a huge change when it's just normal variation.
How to implement:
•If tracking estrogen, progesterone, or FSH: test on day 21 of every cycle (same relative point)
•For men, day-of-week is less critical but consistency matters
Rule 5: Spacing from events
Test relative to major life events and protocol changes consistently.
How to implement:
•Travel, illness, and stress affect labs temporarily
•Schedule draws for weeks when life is stable
•If you're adjusting peptide dose, wait 4-6 weeks before testing to let levels stabilize
•Record any major events (infection, injury, diet change, travel) adjacent to draw dates
Building the Baseline: Months 1-3
Your first 3 months of testing establish the baseline for comparison.
Month 1 draw (Week 0-2 if starting protocol):
•Ideally pre-protocol to establish true baseline
•Or as early as possible after starting (week 2-3)
•Full metabolic panel, hormones, lipids, any protocol-specific markers
Month 2 draw (Week 8-10):
•Same conditions as month 1
•Early response check
•Don't expect dramatic changes; just ensure consistency
Month 3 draw (Week 12-14):
•True post-protocol response point for many markers
•Now you have three points and can see a trend emerging
By month 3, you've established:
•Your baseline (month 1)
•Early response or non-response (month 2)
•Stable plateau or continued improvement (month 3)
Interpreting Changes: Real vs Noise
What counts as "real change":
•IGF-1: Change of >10 ng/mL is meaningful (outside normal monthly variation)
•Glucose (fasting): Change of >5 mg/dL is meaningful
•Total cholesterol: Change of >10 mg/dL is meaningful
•Triglycerides: Change of >20 mg/dL is meaningful
•Testosterone: Change of >50 ng/dL is meaningful
•ApoB: Change of >5 mg/dL is meaningful
What's likely noise (day-to-day variation, not real change):
•Changes smaller than the thresholds above
•Single anomalous result after consistent trends
•Changes that reverse immediately in the next draw
Example: Your IGF-1 was 145, 147, 146 ng/mL over three months (stable). Month 4 it's 138 ng/mL. This is noise—likely due to a slightly different fasting state or lab variation. Don't adjust your dose. Next month, expect it to return to the 145-150 range.
Trend Analysis: Identifying Patterns
Linear improvement (steady climb):
•Month 1: 100 ng/mL
•Month 2: 115 ng/mL
•Month 3: 130 ng/mL
•Month 4: 140 ng/mL
•Interpretation: Your dose is working; continue or increase modestly
•Action: Maintain dose; retest at month 6
Plateau (improvement stops):
•Month 1: 100 ng/mL
•Month 2: 125 ng/mL
•Month 3: 130 ng/mL
•Month 4: 130 ng/mL
•Interpretation: You've reached your response threshold for this dose
•Action: If target reached, maintain. If below target, increase dose
Decline after improvement (worked, then stopped):
•Month 1: 100 ng/mL
•Month 2: 125 ng/mL
•Month 3: 120 ng/mL
•Month 4: 110 ng/mL
•Interpretation: Possible issues—protocol non-adherence, batch quality change, developing tolerance, or lab error
•Action: Verify dosing consistency; check batch/vial; retest at same lab
No change (flat line):
•All months: 95-105 ng/mL
•Interpretation: Peptide isn't working, dose is too low, protocol is wrong, or conditions prevent response
•Action: Increase dose by 0.5-1 unit; change timing; rule out secondary factors (storage, injection technique); retest after 4 weeks
Visualization: Seeing Your Trend
Data table method:
```
Month | IGF-1 | Date | Fasting | Lab
1 | 100 | 1/15 | 11h | Quest
2 | 115 | 2/15 | 10h | Quest
3 | 130 | 3/15 | 12h | Quest
4 | 140 | 4/15 | 10h | Quest
```
Spreadsheet graphing: Plot your biomarkers as a line chart. A graph makes trends immediately visual and catches anomalies.
MyProtocolStack platform: Upload results and the platform automatically visualizes your trends, flagging anomalies and correlating with your dose logs.
Handling Lab Reference Range Changes
Some labs update their reference ranges. A "normal" range that was 80-200 mg/dL last year becomes 75-210 mg/dL this year. Don't get confused—compare your absolute values, not your position within the range.
How to handle:
•Focus on your numeric trend: 140, 145, 150 ng/mL (rising smoothly)
•Ignore if it moves from "high-normal" to "normal" due to range updates
•Confirm major shifts in your result by asking the lab if their range changed
Multivariate Analysis: Connecting Multiple Markers
One biomarker rarely tells the whole story. Compare patterns across related markers:
GH protocol assessment:
•IGF-1 rises ✓
•Glucose fasting stable or slightly elevated (possible, due to IGF-1) ✓
•Insulin fasting slightly elevated (possible) ✓
•Joint pain absent ✓
•Conclusion: Protocol working well
GLP-1 protocol assessment:
•Weight dropping consistently ✓
•HbA1c improving ✓
•Triglycerides improving ✓
•LDL-C slightly elevated but ApoB stable (particle count unchanged, just larger particles) ✓
•Conclusion: Metabolic improvements on track; lipid response favorable
Protocol not working:
•Dose log shows consistency ✓
•But IGF-1 flat, glucose not improved, weight stable ✗
•Possible explanations: Bad batch, storage issue, injection technique problem, genetics not responsive, underdose
•Next step: Increase dose modestly and retest in 4-6 weeks
Frequency of Testing: Balancing Data and Cost
First 6 months (establishing protocol): Test every 4 weeks (or 6-8 weeks minimum)
•You're adjusting dose and validating the approach
•Frequent testing guides decisions
Months 6-12 (stabilization): Test every 8-12 weeks
•Protocol is established; changes are slower
•Monthly testing adds noise, not signal
Year 2+: Test every 3-6 months or quarterly
•Long-term stability monitoring
•Catch drift or age-related changes annually
Seasonal Variation Considerations
Some biomarkers vary by season:
•**Vitamin D**: Seasonal low in winter
•**IGF-1**: Slight seasonal variation (lower in winter for some people)
•**Mood markers**: Seasonal affective patterns
How to account for it:
•If possible, test at the same season each year
•Note the season when major changes occur
•Don't over-interpret seasonal variation as protocol failure
Red Flags: When to Retest Immediately
Retest outside your regular schedule if:
•A result is dramatically outside your normal range (>20% shift)
•You develop unexpected symptoms (sudden joint pain, unusual fatigue)
•You suspect a lab error (result doesn't match how you feel)
•You've made a major dose adjustment (retest 4-6 weeks after)
Using MyProtocolStack for Trend Correlation
MyProtocolStack automates trend analysis by:
•Visualizing your biomarkers on a unified timeline
•Flagging anomalies (values far outside your typical range)
•Correlating lab results with dose logs (which dose produced which result?)
•Allowing you to annotate (diet change, illness, travel) to explain anomalies
•Exporting your trend data for your healthcare provider
Building Your Biomarker Story
Over 12 months of consistent tracking, your biomarkers tell a story:
•Months 1-2: Initial baseline and early response
•Months 3-6: Dose optimization and stabilization
•Months 6-12: Long-term response and fine-tuning
•Year 2+: Sustainable protocol and preventing drift
This story is only valid if you've compared apples to apples—same lab, same time, same conditions, every month.
Key Takeaways
•**Same lab**: Different labs use different assays; stay with one
•**Same time of day**: Hormones vary 10-50% by time of day
•**Same fasting state**: Fed vs fasted changes glucose, lipids dramatically
•**Same spacing from events**: Test when life is stable; avoid travel, illness, stress
•**Real vs noise**: Only changes >10% are meaningful; smaller shifts are normal variation
•**Monthly testing first 6 months**: Then every 8-12 weeks; quarterly after year 1
•**Visualization**: Graph your results; trends become obvious
This article is for informational and educational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting, adjusting, or stopping any peptide protocol. MyProtocolStack is a protocol tracking and blood work analysis platform — it is not a medical device and does not provide clinical recommendations.